Healthlink Capital

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 13, 2017	Lyndra Therapeutics	$23.0M Series A	Polaris Partners	GF Securities, Mass General Brigham, Quark Venture, Suffolk Equity, Yonghua Capital

Total Raised

N/A

Valuation

N/A